Table 3.
Effects of ancillary therapies used in combination with an antimicrobial on performance, retreatment percentages, and retreatment intervals
Variable | Experimental ancillary treatment1 | Pooled SEM | Overall P-value2 | |||
---|---|---|---|---|---|---|
NOAC | NSAID | VACC | VITC | |||
Treatment BW,3 kg | ||||||
First treatment | 215 | 214 | 212 | 213 | 3.32 | 0.78 |
Second treatment | 214 | 209 | 212 | 212 | 6.97 | 0.82 |
Third treatment | 211a | 192b | 192b | 192b | 5.63 | 0.01 |
Fourth treatment | 193 | 181 | 190 | 194 | 12.1 | 0.60 |
Average daily gain,4 kg | ||||||
First to second | −0.54 | −0.48 | −0.61 | −1.01 | 0.40 | 0.63 |
Second to third | −0.13a | −1.30b | −1.90b | −1.41b | 0.42 | <0.01 |
Third to fourth | −0.31 | −0.28 | −0.48 | −0.45 | 0.72 | 0.99 |
First to fourth | −0.89 | −0.97 | −1.16 | −1.01 | 0.34 | 0.94 |
Retreatments,5 % | ||||||
Second treatment | 48.8 | 51.3 | 37.5 | 43.8 | 11.4 | 0.26 |
Third treatment | 55.1 | 42.7 | 50.4 | 44.7 | 13.5 | 0.67 |
Fourth treatment | 29.7a,x | 35.7a,y | 59.2y,z | 67.2b,z | 12.1 | 0.05 |
Third treatment, % of first | 30.0 | 25.0 | 21.3 | 22.5 | 9.63 | 0.54 |
Fourth treatment, % of first | 8.75 | 8.75 | 12.5 | 15.0 | 5.48 | 0.50 |
Time to treatment,6 d | ||||||
First treatment | 7.53 | 7.28 | 7.30 | 7.27 | 1.36 | 0.82 |
Second treatment | 19.4 | 16.7 | 18.0 | 16.9 | 3.34 | 0.31 |
Third treatment | 26.4a | 18.2b | 18.3b | 17.9b | 2.22 | <0.001 |
Fourth treatment | 31.0 | 26.7 | 24.7 | 25.8 | 2.66 | 0.30 |
a,bWithin a row means with different superscripts differ (P ≤ 0.05).
x–zWithin a row means with different superscripts tend to differ (P ≤ 0.10).
1Experimental ancillary therapy treatments administered at each antimicrobial treatment for bovine respiratory disease: NOAC = antimicrobial only, no ancillary therapy; NSAID = intravenous flunixin meglumine injection; VACC = revaccination with an intranasal viral vaccine; VITC = intramuscular vitamin C injection.
2 P-values are included for the overall F test.
3Treatment BW was the BW in kilograms with a calculated 2% shrink at the time of bovine respiratory disease (BRD) treatment.
4Treatment ADG was calculated from the shrunk (2%) BW in kilograms and individual days on feed between the BRD treatments.
5Retreatment percentages were calculated by taking the number of calves treated for BRD divided by the number of calves treated for BRD the previous time in the case of second treatment, third treatment, and fourth treatment or by taking the number of calves treated for BRD divided by the number of calves treated for BRD initially in the case of third treatment percentage of first and fourth treatment percentage of first.
6Average length of time in days from arrival until the BRD treatment.